Compare
5 stocks, side by sideRelative performance · rebased to 100
RAPPMESOIOVATYRAGLUE
| RAPPRapport Therapeutics, Inc. | MESOMesoblast Limited | IOVAIovance Biotherapeutics, Inc. | TYRATyra Biosciences, Inc. | GLUEMonte Rosa Therapeutics, Inc. | |
|---|---|---|---|---|---|
| Smart Score | 9/10 | 5/10 | 7/10 | 4/10 | 2/10 |
| Price | $45.98 | $16.40 | $8.71 | $26.72 | $14.28 |
| 1 month | -0.84% | +5.0% | +41% | -0.45% | -9.2% |
| 1 year | +215% | +3.0% | +248% | +147% | +213% |
| 5 year | - | +9.8% | -62% | - | -57% |
| P/E (TTM) | -17.7 | -74.3 | -9.5 | -12.3 | - |
| P/E vs sector | - | - | - | - | - |
| Market cap | $1.9B | $1.9B | $1.9B | $1.8B | $1.8B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.